Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia (Q36100102)

12 August 2017

title

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia (English)

1 reference

12 August 2017

1 reference

1 reference

Tetsuya Niihori

1 reference

12 August 2017

Yoko Aoki

1 reference

12 August 2017

Hirofumi Ohashi

1 reference

12 August 2017

Kenji Kurosawa

1 reference

12 August 2017

Tatsuro Kondoh

1 reference

12 August 2017

Satoshi Ishikiriyama

1 reference

12 August 2017

Hiroshi Kawame

1 reference

12 August 2017

Hotaka Kamasaki

1 reference

12 August 2017

Tsutomu Yamanaka

1 reference

12 August 2017

Fumio Takada

1 reference

12 August 2017

Kimio Nishio

1 reference

12 August 2017

Masahiro Sakurai

1 reference

12 August 2017

Hiroshi Tamai

1 reference

12 August 2017

Tatsuro Nagashima

1 reference

12 August 2017

Yoichi Suzuki

1 reference

12 August 2017

Shigeo Kure

1 reference

12 August 2017

Kunihiro Fujii

1 reference

12 August 2017

Masue Imaizumi

1 reference

12 August 2017

Yoichi Matsubara

1 reference

12 August 2017

language of work or name

1 reference

15 April 2005

1 reference

Journal of Human Genetics

12 August 2017

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

192-202

1 reference

Cas mediates transcriptional activation of the serum response element by Src.

12 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10038-005-0239-7

Genotype-phenotype correlations in Noonan syndrome

21 January 2018

1 reference

12 December 2020

Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression

1 reference

12 December 2020

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

1 reference

12 December 2020

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

12 December 2020

Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

1 reference

12 December 2020

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

1 reference

12 December 2020

PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome

1 reference

12 December 2020

Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report

1 reference

12 December 2020

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

1 reference

12 December 2020

Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2

1 reference

12 December 2020

Shp-2 tyrosine phosphatase: signaling one cell or many

1 reference

12 December 2020

Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps

1 reference

12 December 2020

Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2.

1 reference

12 December 2020

Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome

1 reference

12 December 2020

Noonan syndrome: a review

1 reference

12 December 2020

Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes.

1 reference

12 December 2020

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

1 reference

12 December 2020

Noonan syndrome: the changing phenotype

1 reference

12 December 2020

Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia

1 reference

12 December 2020

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

1 reference

12 December 2020

A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains

1 reference

12 December 2020

PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning

1 reference

12 December 2020

Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: potential diagnostic and therapeutic perspectives

1 reference

12 December 2020

Juvenile myelomonocytic leukemia and Noonan syndrome

1 reference

12 December 2020

Crystal structure of the tyrosine phosphatase SHP-2

1 reference

12 December 2020

Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas

1 reference

12 December 2020

Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.

1 reference

12 December 2020

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

1 reference

12 December 2020

1 reference

12 December 2020

PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor

1 reference

12 December 2020

Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation

1 reference

12 December 2020

PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.

1 reference

12 December 2020

10.1007/S10038-005-0239-7

Identifiers

DOI

1 reference

12 August 2017

1 reference